Nuveen Asset Management, LLC V Tv Therapeutics Inc. Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.27 - $3.44 $1.69 Million - $2.56 Million	-744,848 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.97 - $2.89 $1.39 Million - $2.03 Million	703,436 Added 1698.63%	744,848 $2.1 Million
Q3 2020 Nov 16, 2020	BUY	$1.7 - $2.98 $17,929 - $31,430	10,547 Added 34.17%	41,412 $74,000
Q2 2020 Aug 14, 2020	BUY	$1.74 - $3.19 $53,705 - $98,459	30,865 New	30,865 $69,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.